Symposium Focuses on Inflammatory Lung Diseases
The inaugural Progressive Pulmonary Fibrosis Symposium brought leading lung disease researchers and clinicians to the institute.
The inaugural Progressive Pulmonary Fibrosis Symposium brought leading lung disease researchers and clinicians to the institute.
Donna Zhang, Ph.D., has dedicated her career to unraveling how cells’ defense system against oxidative stress, controlled by a gene called NRF2, can be strategically activated to prevent disease — or disarmed to help destroy cancer cells. Donna Zhang, Ph.D. The Big Picture What if…
From the journal Therapeutic Advances in Respiratory Disease. During the pandemic, a primary cause of death for people hospitalized with COVID-19 was acute respiratory distress syndrome, or ARDS. A lack of effective medications has been an ongoing problem, including several clinical trial failures. A team led by…
When Dr. Joe G.N. “Skip” Garcia, M.D., was director of pulmonary and critical care medicine at Johns Hopkins University, his laboratory identified NAMPT (nicotinamide phosphoribosyltransferase) as a master regulator of inflammation and innate immunity. Inside the cell, NAMPT is an enzyme that plays a crucial role in…
Two new studies show preterm births and obesity-related liver disease both improve after treatment with this antibody.
innate immunity and your health Controlling Runaway Inflammation At the Center for Inflammation Science and Systems Medicine, our mission is to advance the understanding of the complex role of inflammation…
From his lab and offices in Jupiter, Joe G.N. “Skip” Garcia, M.D. is helping advance clinical translational efforts at UF Health and The Wertheim UF Scripps Institute. He discusses his life's work and vision for the future.
Joe G.N. “Skip” Garcia, M.D., a member of the National Academy of Medicine, has been named associate VP for research at UF Health. He will be based at UF Scripps in Jupiter, Florida.